Recently, we demonstrated that the functional reduction of NKCC1 by genetic or pharmacologic treatment suppressed nuclear factor-κB (NF-κB) and reduced the severity of IR-ALI in mice (24). The gene discussed is SLC12A2; the disease is acute respiratory distress syndrome.